Initiation and Titration of Amaryl

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.

Also called NCT01144728

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 172 participants (enrolled count) (from the registry)
Sponsor
  • Sanofi Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01144728
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Kazakhstan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01144728. Allocation not applicable; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2010-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Initiation and Titration of Amaryl
Acronym
AMIT KZ
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
GLIMEPIRIDE + METFORMIN
Lead sponsor
Sanofi (class: industry)

Record details

Record id
cardio:ct-nct01144728
Content hash
7c5ce01fd7c2eaedf3b635d24ff3d2cfc4284df4f64f96072e3c6bd4095176c6